Case number 2022-1147
Amgen Inc. v. Sandoz Inc. > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| May 26, 2023 | 62 | Mandate issued to the United States District Court for the District of New Jersey. Service as of this date by the Clerk of Court. [926106] [22-1147, 22-1149, 22-1150, 22-1151] [MVH] [Entered: 05/26/2023 09:50 AM] (2) |
| Apr 23, 2023 | 0 | AMGEN INC. v. SANDOZ INC. [OPINION] [precedential] (0) |
| Apr 19, 2023 | 61 | JUDGMENT. AFFIRMED. Terminated on the merits after oral argument. COSTS: No Costs. Mandate to issue in due course. For information regarding costs, petitions for rehearing, and petitions for writs of certiorari click here. Service as of this date by the Clerk of Court. [917623] [22-1147, 22-1149, 22-1150, 22-1151] [MVH] [Entered: 04/19/2023 10:04 AM] (2) |
| Apr 19, 2023 | 60 | OPINION filed for the court by Lourie, Circuit Judge; Cunningham, Circuit Judge and Stark, Circuit Judge. Precedential Opinion. Service as of this date by the Clerk of Court. [917620] [MVH] [Entered: 04/19/2023 09:56 AM] (28) |
| Feb 8, 2023 | 59 | Submitted after ORAL ARGUMENT to Panel: Lourie, Circuit Judge; Cunningham, Circuit Judge and Stark, Circuit Judge.Arguing counsel: Maureen L. Rurka for Sandoz Inc. and Steven J. Horowitz for Amgen Inc.Oral Argument Audio available here. [902899] [MJL] [Entered: 02/08/2023 03:09 PM] (0) |
| Jan 25, 2023 | 58 | **TEXT ONLY** ORDER granting motion to withdraw attorney [57] filed by Appellant Sandoz Inc. Service as of this date by the Clerk of Court. This order has been issued without an attached document and is official and binding. [899548] [MVH] [Entered: 01/25/2023 02:26 PM] (0) |
| Jan 25, 2023 | 57 | MOTION of Appellant Sandoz Inc. to withdraw counsel Noorossadat Torabi. Service: 01/25/2023 by email. [899530] [22-1147] [Maureen Rurka] [Entered: 01/25/2023 01:46 PM] (5) |
| Dec 22, 2022 | 56 | Response to notice of oral argument from Appellant Sandoz Inc.. Service: 12/22/2022 by email. [892549] [22-1147] [Maureen Rurka] [Entered: 12/22/2022 04:18 PM] (1) |
| Dec 21, 2022 | 55 | Response to notice of oral argument from Cross-Appellant Amgen Inc.. Service: 12/21/2022 by email. [892116] [22-1147] [Steven Horowitz] [Entered: 12/21/2022 01:55 PM] (1) |
| Dec 16, 2022 | 54 | NOTICE OF ORAL ARGUMENT. Panel: 2302G. Case scheduled February 8, 2023. Response to Notice of Oral Argument due: 12/30/2022. Please review the attached Notice. The response to notice of oral argument form can be found here. The Oral Argument Guide can be found here. Service as of this date by the Clerk of Court. [891213] [MJL] [Entered: 12/16/2022 03:11 PM] (2) |
| Sep 22, 2022 | 53 | The following conflict dates submitted by Steven J. Horowitz for Amgen Inc. have been accepted by the court: 03/08/2023, 03/09/2023, 03/10/2023. [873297] [MJL] [Entered: 09/22/2022 08:45 AM] (0) |
| Sep 20, 2022 | 52 | Notice from Cross-Appellant Amgen Inc. regarding conflicts with oral argument. Service: 09/20/2022 by email. [872863] [22-1147] [Steven Horowitz] [Entered: 09/20/2022 04:27 PM] (2) |
| Sep 20, 2022 | 51 | The following conflict dates submitted by Maureen L. Rurka for Sandoz Inc. have been accepted by the court: 03/06/2023, 03/07/2023. [872846] [MJL] [Entered: 09/20/2022 04:14 PM] (0) |
| Sep 20, 2022 | 50 | Notice from Appellant Sandoz Inc. regarding conflicts with oral argument. Service: 09/20/2022 by email. [872842] [22-1147] [Maureen Rurka] [Entered: 09/20/2022 04:09 PM] (4) |
| Sep 15, 2022 | 48 | 6 paper copies of Doc. No. [43], [35], [27] received from Appellants Sandoz Inc. and Zydus Pharmaceuticals (USA) Inc.. [872251] [VDW] [Entered: 09/16/2022 01:06 PM] (0) |
| Sep 14, 2022 | 49 | 6 paper copies of Doc. No. [32], [38] received from Cross-Appellant Amgen Inc.. [872255] [VDW] [Entered: 09/16/2022 01:18 PM] (0) |
| Sep 13, 2022 | 46 | Notice to Advise of Scheduling Conflicts. Arguing counsel must advise of, and show good cause for, any scheduling conflicts during the upcoming court session months listed in the attached notice. The Response to Notice to Advise of Scheduling Conflicts can be found here. The Oral Argument Guide can be found here. [871450] [KMH] [Entered: 09/13/2022 02:20 PM] (1) |
| Sep 13, 2022 | 47 | Outstanding paper copies of all briefs and appendices must be submitted within five business days from the date of issuance of this notice. See Fed. Cir. R. 25(c)(3)(A). [871451] [KMH] [Entered: 09/13/2022 02:22 PM] (0) |
| Sep 1, 2022 | 45 | REMINDER: Attorney Gregory Bonifield is reminded of their responsibility per Fed. Cir. R. 47.3 to promptly submit an amended Entry of Appearance (EOA) and/or update their contact information via the PACER Service Center as information changes during the pendency of the appeal. Failure to comply with these Rules may delay the timely processing of your case or result in adverse action. [869396] [KMH] [Entered: 09/01/2022 09:22 AM] (0) |
| Aug 24, 2022 | 44 | Certificate of Compliance with Fed. Cir. R. 25.1(c)(2) for Cross-Appellant Amgen Inc.. Service: 08/24/2022 by email. [868149] [22-1147] [Steven Horowitz] [Entered: 08/24/2022 03:50 PM] (2) |
| Aug 24, 2022 | 43 | MODIFIED ENTRY: APPENDIX FILED by Appellants Sandoz Inc., Zydus Pharmaceuticals (USA) Inc. and Cross-Appellant Amgen Inc.. Service: 08/24/2022 by email. [868143] --[Edited 09/13/2022 by KMH - compliance review complete] [Maureen Rurka] [Entered: 08/24/2022 03:35 PM] (1602) |
| Aug 24, 2022 | 42 | Certificate of Compliance with Fed. Cir. R. 25.1(c)(2) for Appellants Sandoz Inc. and Zydus Pharmaceuticals (USA) Inc.. Service: 08/24/2022 by email. [868103] [22-1147] [Maureen Rurka] [Entered: 08/24/2022 01:30 PM] (3) |
| Aug 24, 2022 | 41 | Joint Statement of Compliance with Fed. Cir. R. 33 for Cross-Appellant Amgen Inc. and Appellants Sandoz Inc. and Zydus Pharmaceuticals (USA) Inc.. Service: 08/24/2022 by email. [868095] [22-1147] [Maureen Rurka] [Entered: 08/24/2022 01:07 PM] (3) |
| Aug 22, 2022 | 40 | Clerk's Note to the File: The time to file the appendix has been extended by 5 days. See [39] and Fed. Cir. R. 26(b)(4). [867710] [KMH] [Entered: 08/22/2022 04:47 PM] (0) |
| Aug 19, 2022 | 39 | Notice from Appellants Zydus Pharmaceuticals (USA) Inc. and Sandoz Inc. of Additional Time Needed to File Joint Appendix (Unopposed). Service: 08/19/2022 by email. [867420] [22-1147] [Maureen Rurka] [Entered: 08/19/2022 04:41 PM] (9) |
| Aug 12, 2022 | 38 | MODIFIED ENTRY: REPLY BRIEF FILED by Cross-Appellant Amgen Inc.. Service: 08/12/2022 by email. Unless ordered otherwise, any responsive deadline runs from the date of service of this brief. See Fed. Cir. R. 31. [866383] --[Edited 08/17/2022 by KMH - compliance review complete] [Steven Horowitz] [Entered: 08/12/2022 02:26 PM] (36) |
| Jul 5, 2022 | 37 | **TEXT ONLY** ORDER granting motion to extend time to file brief [36] filed by Cross-Appellant Amgen Inc.. The reply brief is due 08/12/2022. Service as of this date by the Clerk of Court. This order has been issued without an attached document and is official and binding. [858927] [JCW] [Entered: 07/05/2022 09:09 AM] (0) |
| Jul 1, 2022 | 36 | MOTION of Cross-Appellant Amgen Inc. to extend the time to 08/12/2022 to file brief. Service: 07/01/2022 by email. [858883] [22-1147] [Steven Horowitz] [Entered: 07/01/2022 05:51 PM] (9) |
| Jun 22, 2022 | 35 | MODIFIED ENTRY: REPLY BRIEF FILED by Appellants Sandoz Inc. and Zydus Pharmaceuticals (USA) Inc.. Service: 06/22/2022 by email. Unless ordered otherwise, any responsive deadline runs from the date of service of this brief. See Fed. Cir. R. 31. [856846] --[Edited 06/22/2022 by JCW - compliance review complete] [Maureen Rurka] [Entered: 06/22/2022 04:14 PM] (82) |
| May 3, 2022 | 34 | **TEXT ONLY** ORDER granting motion to extend time to file brief [33] filed by Appellants Sandoz Inc. and Zydus Pharmaceuticals (USA) Inc. The reply brief is due 06/22/2022. Service as of this date by the Clerk of Court. This order has been issued without an attached document and is official and binding. [847235] [JCW] [Entered: 05/03/2022 03:05 PM] (0) |
| May 3, 2022 | 33 | MOTION of Appellants Sandoz Inc. and Zydus Pharmaceuticals (USA) Inc. to extend the time to 06/22/2022 to file brief. Service: 05/03/2022 by email. [847233] [22-1147] [David Abramowitz] [Entered: 05/03/2022 02:54 PM] (10) |
| Apr 13, 2022 | 32 | MODIFIED ENTRY: RESPONSE BRIEF FILED by Cross-Appellant Amgen Inc.. Service: 04/13/2022 by email. Unless ordered otherwise, any responsive deadline runs from the date of service of this brief. See Fed. Cir. R. 31. [842799] --[Edited 04/13/2022 by JCW - compliance review complete] [Steven Horowitz] [Entered: 04/13/2022 02:43 PM] (107) |
| Mar 8, 2022 | 31 | Amended Certificate of Interest for Appellant Zydus Pharmaceuticals (USA) Inc.. Service: 03/08/2022 by email. [835495] [22-1147] [David Abramowitz] [Entered: 03/08/2022 03:47 PM] (3) |
| Feb 8, 2022 | 30 | **TEXT ONLY** ORDER granting motion to extend time to file brief [29] filed by Cross-Appellant Amgen Inc. The response brief is due 04/13/2022. Service as of this date by the Clerk of Court. This order has been issued without an attached document and is official and binding. [829794] [JCW] [Entered: 02/08/2022 03:48 PM] (0) |
| Feb 8, 2022 | 29 | MOTION of Cross-Appellant Amgen Inc. to extend the time to 02/08/2022 to file brief. Service: 02/08/2022 by email. [829788] [22-1147] [Steven Horowitz] [Entered: 02/08/2022 03:41 PM] (9) |
| Jan 31, 2022 | 28 | Amended Certificate of Interest for Appellant Zydus Pharmaceuticals (USA) Inc.. Service: 01/31/2022 by email. [828138] [22-1147] [David Abramowitz] [Entered: 01/31/2022 08:41 PM] (3) |
| Jan 31, 2022 | 27 | MODIFIED ENTRY: OPENING BRIEF FILED by Appellants Sandoz Inc. and Zydus Pharmaceuticals (USA) Inc. Service: 01/31/2022 by email. Unless ordered otherwise, any responsive deadline runs from the date of service of this brief. See Fed. Cir. R. 31. [828135] --[Edited 02/01/2022 by JCW - compliance review complete] [Maureen Rurka] [Entered: 01/31/2022 07:54 PM] (316) |
| Jan 28, 2022 | 26 | Amended Certificate of Interest for Appellant Sandoz Inc.. Service: 01/28/2022 by email. [827658] [22-1147] [Maureen Rurka] [Entered: 01/28/2022 12:28 PM] (3) |
| Jan 28, 2022 | 25 | Amended Entry of appearance for Maureen L. Rurka; Samantha Lerner; Noorossadat Torabi; Eimeric Reig-Plessis as counsel for Appellant Sandoz Inc.. Service: 01/28/2022 by email. [827652] [22-1147] [Maureen Rurka] [Entered: 01/28/2022 12:13 PM] (2) |
| Jan 14, 2022 | 24 | Official caption revised to reflect appellees' non-participation. (see attached). Service as of this date by the Clerk of Court. [824734] [JCW] [Entered: 01/14/2022 02:38 PM] (2) |
| Jan 14, 2022 | 23 | Notice from Cross-Appellant Amgen Inc. Notice Pursuant to the Practice Notes to Federal Circuit Rule 12. Service: 01/14/2022 by email. [824728] [22-1147] [Steven Horowitz] [Entered: 01/14/2022 02:19 PM] (3) |
| Jan 12, 2022 | 22 | Notice to Appellees Actavis LLC, Alkem Laboratories Ltd., Amneal Pharmaceuticals LLC, Annora Pharma Private Limited, Aurobindo Pharma Ltd., Aurobindo Pharma USA, Inc., Cipla Limited, Dr. Reddy's Laboratories, Inc., Dr. Reddy's Laboratories, Ltd., Emcure Pharmaceuticals Ltd., Glenmark Pharmaceuticals Limited, Heritage Pharmaceuticals Inc., Hetero USA, Inc., MSN Laboratories Private Ltd., Macleods Pharmaceuticals Ltd., Mankind Pharma Ltd., Pharmascience Inc., Prinston Pharmaceutical Inc. and Torrent Pharmaceuticals Ltd.: The record of this case indicates that no Entry of Appearance under FCR 47.3(b), Certificate of Interest under FCR 47.4, and/or Docketing Statement under FCR 33.1(a) has been filed. Failure to file required documents may result in dismissal or other action as deemed appropriate by the court. See FCR 25(h). Service as of this date by the Clerk of Court. [824060] [JCW] [Entered: 01/12/2022 09:24 AM] (0) |
| Dec 22, 2021 | 21 | **TEXT ONLY** ORDER granting motion to extend time to file brief [20] filed by Appellants Sandoz Inc. and Zydus Pharmaceuticals (USA) Inc. The opening brief is due 01/31/2022. Service as of this date by the Clerk of Court. This order has been issued without an attached document and is official and binding. [820630] [JCW] [Entered: 12/22/2021 01:33 PM] (0) |
| Dec 22, 2021 | 20 | MOTION of Appellants Sandoz Inc. and Zydus Pharmaceuticals (USA) Inc. to extend the time to 01/31/2022 to file brief. Service: 12/22/2021 by email. [820621] [22-1147] [Maureen Rurka] [Entered: 12/22/2021 01:17 PM] (9) |
| Dec 3, 2021 | 19 | Corrected Entry of appearance for Michael J. Gaertner; David B. Abramowitz; Hugh S. Balsam; Carolyn A. Blessing; Emily L. Savas; August M. Melcher as counsel for Appellant Zydus Pharmaceuticals (USA) Inc.. Service: 12/03/2021 by email. [816176] [22-1147] [David Abramowitz] [Entered: 12/03/2021 02:42 PM] (2) |
| Dec 1, 2021 | 18 | NOTICE OF NON-COMPLIANCE: The submission of Appellant Zydus Pharmaceuticals (USA) Inc., Entry of Appearance [17], is not in compliance with the rules of this court (see attached). Compliant document due on 12/08/2021. Service as of this date by the Clerk of Court. [815547] [JCW] [Entered: 12/01/2021 10:40 AM] (2) |
| Nov 30, 2021 | 17 | Amended Entry of appearance for Michael J. Gaertner; Hugh S. Balsam; David B. Abramowitz; Carolyn A. Savas; Emily L. Savas; August M. Melcher as counsel for Appellant Zydus Pharmaceuticals (USA) Inc.. Service: 11/30/2021 by email. [815357] [22-1147] This document is non-compliant. See Doc No.[18] [David Abramowitz] [Entered: 11/30/2021 02:09 PM] (2) |
| Nov 29, 2021 | 16 | Docketing Statement for the Cross-Appellant Amgen Inc.. Service: 11/29/2021 by email. [815172] [22-1147] [Steven Horowitz] [Entered: 11/29/2021 07:00 PM] (2) |
| Nov 29, 2021 | 15 | Certificate of Interest for Cross-Appellant Amgen Inc.. Service: 11/29/2021 by email. [815171] [22-1147] [Steven Horowitz] [Entered: 11/29/2021 06:59 PM] (2) |
| Nov 29, 2021 | 14 | Entry of appearance for Steven Horowitz; Joshua Fougere; Sue Wang; Paul Rogerson; Julia Tabat; Stuart L. Watt; Wendy Whiteford; Eric M. Agovino; Christina Nichole Gifford; Dennis J. Smith; Gregory Bonifield; George Frank Pappas; Jeffrey B. Elikan; Alexa Hansen; Michael Kennedy as counsel for Cross-Appellant Amgen Inc.. Service: 11/29/2021 by email. [815170] [22-1147] [Steven Horowitz] [Entered: 11/29/2021 06:55 PM] (4) |
| Nov 29, 2021 | 13 | Docketing Statement for the Appellant Sandoz Inc.. Service: 11/29/2021 by email. [815165] [22-1147] [Maureen Rurka] [Entered: 11/29/2021 05:58 PM] (2) |
| Nov 29, 2021 | 12 | Certificate of Interest for Appellant Sandoz Inc.. Service: 11/29/2021 by email. [815164] [22-1147] [Maureen Rurka] [Entered: 11/29/2021 05:54 PM] (3) |
| Nov 29, 2021 | 11 | Entry of appearance for Maureen L. Rurka; Samantha Lerner; Noorossadat Torabi as counsel for Appellant Sandoz Inc.. Service: 11/29/2021 by email. [815161] [22-1147] [Maureen Rurka] [Entered: 11/29/2021 05:42 PM] (2) |
| Nov 22, 2021 | 10 | Docketing Statement for the Appellant Zydus Pharmaceuticals (USA) Inc.. Service: 11/22/2021 by email. [814186] [22-1147] [David Abramowitz] [Entered: 11/22/2021 03:29 PM] (2) |
| Nov 22, 2021 | 9 | Certificate of Interest for Appellant Zydus Pharmaceuticals (USA) Inc.. Service: 11/22/2021 by email. [814185] [22-1147] [David Abramowitz] [Entered: 11/22/2021 03:28 PM] (4) |
| Nov 22, 2021 | 8 | Entry of appearance for Michael J. Gaertner; Hugh S. Balsam; David B. Abramowitz; Carolyn A. Blessing as counsel for Appellant Zydus Pharmaceuticals (USA) Inc.. Service: 11/22/2021 by email. [814184] [22-1147] [David Abramowitz] [Entered: 11/22/2021 03:27 PM] (2) |
| Nov 18, 2021 | 7 | Note to File: The following cases are consolidated: 22-1147 Lead with 22-1149 Cross-appeal, with 22-1150 Member Case with 22-1151 Cross-Appeal. The parties must file all documents in the lead appeal only. [813519] [22-1147, 22-1149, 22-1150, 22-1151] [JCW] [Entered: 11/18/2021 04:09 PM] (0) |
| Nov 18, 2021 | 6 | ORDER consolidating appeals (22-1147, 22-1149, 22-1150, 22-1151). Appellants opening briefs are due no later than January 14, 2022. Service as of this date by the Clerk of Court. [813518] [22-1147, 22-1150, 22-1149, 22-1151] [JCW] [Entered: 11/18/2021 04:06 PM] (2) |
| Nov 17, 2021 | 5 | NOTICE OF NON-COMPLIANCE: The submission of Appellant Zydus Pharmaceuticals (USA) Inc., Application for Admission [4], is not in compliance with the rules of this court (see attached). Service as of this date by the Clerk of Court. [813173] [JCW] [Entered: 11/17/2021 02:56 PM] (1) |
| Nov 17, 2021 | 4 | Motion of Sponsor for Admission to the Bar for Emily L. Savas for Appellant Zydus Pharmaceuticals (USA) Inc.. Service: 11/17/2021 by clerk. [813157] [22-1147] This document is non-compliant. See Doc No.[5] [David Abramowitz] [Entered: 11/17/2021 02:41 PM] (2) |
| Nov 15, 2021 | 3 | Official caption revised to reflect cross-appeal with 22-1149. (see attached). Service as of this date by the Clerk of Court. [812173] [JCW] [Entered: 11/15/2021 11:06 AM] (2) |
| Nov 12, 2021 | 2 | Note to File: The following cases are consolidated: 22-1147 Lead with 22-1149 Cross-Appeal. The parties must file all documents in the lead appeal only. [811866] [22-1147, 22-1149] [JCW] [Entered: 11/12/2021 12:37 PM] (0) |
| Nov 12, 2021 | 1 | Appeal docketed. Received: 10/28/2021. [811837]Entry of Appearance is due on 11/29/2021. Certificate of Interest is due on 11/29/2021. Docketing Statement is due on 11/29/2021. Appellant's brief is due on 01/11/2022. [JCW] [Entered: 11/12/2021 11:41 AM] (93) |
